Form 4 holding
Director
2seventy bio, Inc.
- Security class
- Common Stock
- Shares / value
- 19,050
- Estimated value
- $71,506
- Report date
- 13 Jun 2023
- Price
- $3.75
- Ownership
- Direct
Ramy Ibrahim
Insider Reports History
- Reporting-owner location
- Cambridge, MA
- Latest reporting-owner signature
-
/s/ Teresa Jurgensen, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Ramy Ibrahim
Form 4 holding
Director
2seventy bio, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 16,900
- Estimated value
- $66,417
- Report date
- 13 Jun 2023
- Price
- $3.93
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Surface Oncology, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 24,000
- Estimated value
- Report date
- 08 Jun 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
bluebird bio, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- Report date
- 11 Nov 2021
- Price
- $1.43
- Ownership
- Direct
Form 4 holding
Director
bluebird bio, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 11 Nov 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Ramy Ibrahim
4
TSVT
2seventy bio, Inc.
- Report period
- 13 Jun 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 15 Jun 2023, 17:03
- Role
- Director
- Next action
- Open filing details
4
Surface Oncology, Inc.
- Report period
- 08 Jun 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 10 Jun 2022, 20:00
- Role
- Director
- Next action
- Open filing details
4
TSVT
2seventy bio, Inc.
- Report period
- 08 Jun 2022
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 09 Jun 2022, 18:20
- Role
- Director
- Next action
- Open filing details
4
BLUE
bluebird bio, Inc.
- Report period
- 11 Nov 2021
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 17 Nov 2021, 07:56
- Role
- Director
- Next action
- Open filing details
4
TSVT
2seventy bio, Inc.
- Report period
- 11 Nov 2021
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 16 Nov 2021, 05:41
- Role
- Director
- Next action
- Open filing details
3
TSVT
2seventy bio, Inc.
- Report period
- 18 Oct 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 18 Oct 2021, 16:13
- Role
- Director
- Next action
- Open filing details
4
BLUE
bluebird bio, Inc.
- Report period
- 15 Jun 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 17 Jun 2021, 16:09
- Role
- Director
- Next action
- Open filing details
4
Surface Oncology, Inc.
- Report period
- 08 Jun 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 10 Jun 2021, 16:30
- Role
- Director
- Next action
- Open filing details